1. Home
  2. AMRX vs LGN Comparison

AMRX vs LGN Comparison

Compare AMRX & LGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Amneal Pharmaceuticals Inc.

AMRX

Amneal Pharmaceuticals Inc.

HOLD

Current Price

$17.94

Market Cap

5.8B

Sector

Health Care

ML Signal

HOLD

Logo Legence Corp.

LGN

Legence Corp.

HOLD

Current Price

$60.63

Market Cap

5.3B

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
AMRX
LGN
Founded
2002
1963
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.8B
5.3B
IPO Year
2018
2025

Fundamental Metrics

Financial Performance
Metric
AMRX
LGN
Price
$17.94
$60.63
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
17
Target Price
$15.60
$59.50
AVG Volume (30 Days)
1.8M
1.3M
Earning Date
05-01-2026
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
157.89
N/A
EPS
0.37
N/A
Revenue
N/A
$2,550,491,000.00
Revenue This Year
$4.48
$53.66
Revenue Next Year
$7.13
$11.99
P/E Ratio
$48.95
N/A
Revenue Growth
N/A
21.53
52 Week Low
$9.20
$28.31
52 Week High
$19.26
$107.24

Technical Indicators

Market Signals
Indicator
AMRX
LGN
Relative Strength Index (RSI) 51.26 43.57
Support Level $16.61 $42.97
Resistance Level $18.13 $70.80
Average True Range (ATR) 0.67 3.75
MACD -0.09 0.35
Stochastic Oscillator 48.32 14.50

Price Performance

Historical Comparison
AMRX
LGN

About AMRX Amneal Pharmaceuticals Inc.

Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE. It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment, which derives maximum revenue, focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.

About LGN Legence Corp.

Legence Corp is a provider of engineering, installation, and maintenance services for critical systems in buildings. It focuses on sectors that have technically demanding buildings, including technology, life sciences, healthcare, and education. Legence specializes in designing, fabricating, and installing complex heating, ventilation, and air conditioning (HVAC), process piping, and other mechanical, electrical, and plumbing (MEP) systems for new facilities and upgrading HVAC, lighting, and building controls in existing facilities to enhance building performance, reliability, and efficiency. The services are mainly provided on a fixed price basis. The company has two reportable segments: Installation and Maintenance, which generates the maximum revenue, and Engineering and Consulting.

Share on Social Networks: